Trademark: QUAISAR DRUG DESIGN PLATFORM
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
QUAISAR DRUG DESIGN PLATFORM
Click here to search for trademarks similar to QUAISAR DRUG DESIGN PLATFORM
Proof of use for QUAISAR DRUG DESIGN PLATFORM
We do not have any records of a proof of use for QUAISAR DRUG DESIGN PLATFORM at this moment.
Click here to add a proof of use for QUAISAR DRUG DESIGN PLATFORM
Possible trademark infringements of QUAISAR DRUG DESIGN PLATFORM
Basic Information about QUAISAR DRUG DESIGN PLATFORM
- Serial Number
- 97760513
- Filing Date
- 19 Jan 2023
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of QUAISAR DRUG DESIGN PLATFORM on the blockchain with WikiTrademarks.io.
- First use of QUAISAR DRUG DESIGN PLATFORM anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 009
- US Codes
- 021; 023; 026; 036; 038
- First use of QUAISAR DRUG DESIGN PLATFORM anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
Who owns QUAISAR DRUG DESIGN PLATFORM?
1. PSIVANT THERAPEUTICS, INC. BOSTON MA
2. ROIVANT DISCOVERY, INC. BOSTON MA
3. Roivant Sciences GmbH Basel MA
Correspondent
- Joyce M. Ferraro FROSS ZELNICK LEHRMAN & ZISSU, P.C.
- 151 WEST 42ND STREET, 17TH FLOOR
- NEW YORK, NY 10036
- UNITED STATES
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io